Guofeng Li Selected Research

prim-O-glucosylcimifugin

1/2022

Protective Effect of Prim-O-Glucosylcimifugin on Ulcerative Colitis and Its Mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guofeng Li Research Topics

Disease

10	Neoplasms (Cancer) 05/2022 - 05/2014
4	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2014
4	Wounds and Injuries (Trauma) 07/2019 - 09/2015
3	Infections 03/2022 - 01/2014
3	Ulcerative Colitis 01/2022 - 11/2020
3	Inflammation (Inflammations) 01/2021 - 06/2016
3	Hemorrhage 02/2019 - 12/2016
2	Burns 05/2022 - 07/2019
2	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 09/2019
2	Body Weight (Weight, Body) 01/2020 - 01/2014
2	Blindness (Hysterical Blindness) 01/2018 - 01/2017
2	Acute Lung Injury 01/2017 - 01/2014
2	Cerebral Malaria 05/2011 - 12/2009
1	Thyroid Nodule (Nodule, Thyroid) 05/2022
1	Hematoma 05/2022
1	Glioma (Gliomas) 02/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Diabetes Mellitus 01/2022
1	Pulmonary Arterial Hypertension 12/2021
1	Brain Infarction 02/2021
1	Brain Ischemia (Cerebral Ischemia) 02/2021
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2021
1	Leukemia 01/2021
1	COVID-19 03/2020
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2020
1	Constipation 01/2020
1	Stroke (Strokes) 01/2020
1	Cerebral Palsy (Spastic Diplegia) 01/2020
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2020
1	Carcinogenesis 01/2020
1	Cardiotoxicity 01/2020
1	Liver Neoplasms (Liver Cancer) 11/2019
1	Hyperuricemia 09/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 09/2019

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
4	Pharmaceutical PreparationsIBA 01/2022 - 05/2011
3	Biological ProductsIBA 11/2020 - 08/2017
3	Hemostatics (Antihemorrhagics)IBA 01/2018 - 12/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 04/2011
2	Ethanol (Ethyl Alcohol)IBA 03/2020 - 09/2019
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2014
2	Glycyrrhizic Acid (Glycyrrhizin)IBA 01/2020 - 08/2017
2	MicellesIBA 11/2019 - 06/2016
2	GraphiteIBA 02/2019 - 12/2016
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2017 - 01/2014
2	Complementary DNA (cDNA)IBA 05/2015 - 01/2014
2	artemisinin (artemisinine)IBA 05/2011 - 12/2009
2	Antimalarials (Antimalarial Agents)IBA 05/2011 - 12/2009
1	HydrogelsIBA 05/2022
1	UCON 50-HB-5100 (F127)IBA 05/2022
1	Saline SolutionIBA 05/2022
1	Adenosine Triphosphate (ATP)IBA 02/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2022
1	Thyroid HormonesIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	prim-O-glucosylcimifuginIBA 01/2022
1	Sildenafil Citrate (Viagra)FDA Link 12/2021
1	Interleukin-10 (Interleukin 10)IBA 02/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2021
1	CamptothecinIBA 01/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2021
1	pedunculosideIBA 11/2020
1	Dextran SulfateIBA 11/2020
1	MicroRNAs (MicroRNA)IBA 09/2020
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 09/2020
1	Voriconazole (Vfend)FDA LinkGeneric 03/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Co-Repressor ProteinsIBA 01/2020
1	Silybin (Lagosa)IBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	MethyltransferasesIBA 01/2020
1	ErianinIBA 01/2020
1	Morphine (MS Contin)FDA LinkGeneric 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2020
1	cupric sulfide (CuS)IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	trioctyl phosphine oxide (TOPO)IBA 11/2019
1	homocamptothecinIBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2019
1	Uric Acid (Urate)IBA 09/2019
1	Oxygen (Dioxygen)IBA 09/2019

Therapy/Procedure

10	Therapeutics 05/2022 - 05/2014
2	Visual Prosthesis 01/2018 - 01/2017
1	Injections 05/2022
1	Immunotherapy 01/2022
1	Neurological Rehabilitation 02/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020
1	Infusion Pumps (Infusion Pump) 11/2019
1	Drug Therapy (Chemotherapy) 11/2019
1	Noninvasive Ventilation 09/2019